An overview of eosinophilic esophagitis in children
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20223576Keywords:
EE, Pediatric allergy, Gastro-esophageal refluxAbstract
Based on the patient's age, eosinophilic esophagitis (EE) has different clinical manifestations. Infants and young children frequently have vague manifestations such difficulty eating, nausea, and discomfort in the abdomen. Despite having symptoms that resemble gastroesophageal reflux, children with EE, do not respond to intensive ant reflux medication. Dysphagia and food impaction became the most common symptoms in adults and adolescents. EE should also be considered when treating adults and children who continue to have heartburn. Pediatric and adult patients frequently have concurrent allergy disorders such asthma, rhinitis, and eczema, in addition to peripheral eosinophilia and increased total blood IgE levels. Mucosal oedema, furrows, exudates, corrugated bands, strictures, and the alleged "crepe paper sign" are some of the endoscopic characteristics of EE. EE is widely seen as a distinct condition from reflux disorder. According to current understanding, the former could be a symptom of eosinophilic gastroenteritis or be induced by cell-mediated food hypersensitivity. Reports back up the effectiveness of steroid treatment or food restriction. To ascertain the cause, enable early clinical identification, and enhance treatment, more research is required.
Metrics
References
Furuta GT. Eosinophilic esophagitis: an emerging clinicopathologic entity. Curr Aller Asthma Rep. 2002;2(1):67-72.
Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointestinal Endoscopy. 2002;56(2):260-70.
Liacouras CA. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr. 2003;37:S23-8.
Orenstein SR, Shalaby TM, Di Lorenzo C, Putnam PE, Sigurdsson L, Kocoshis SA. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol. 2000;95(6):1422-30.
Feczko PJ, Halpert RD, Zonca M. Radiographic abnormalities in eosinophilic esophagitis. Gastrointestinal Radiol. 1985;10(1):321-4.
Landres R, Kuster G, Strum W. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74(6):1298-301.
Picus D, Frank PH. Eosinophilic esophagitis. Am J Roentgenol. 1981;136(5):1001-3.
Lee RG. Marked eosinophilia in esophageal mucosal biopsies. Am J Surg Pathol. 1985;9(7):475-9.
Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. Digestive Dis Sci. 1993;38(1):109-16.
Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503-12.
Straumann A, Bauer M, Fischer B, Blaser K, Simon H-U. Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Aller Clin Immunol. 2001;108(6):954-61.
Jyonouchi S, Smith CL, Saretta F. Invariant natural killer T cells in children with eosinophilic esophagitis. Clinical & Experimental Allergy. 2014;44(1):58-68.
Noti M, Wojno EDT, Kim BS. Thymic stromal lymphopoietin–elicited basophil responses promote eosinophilic esophagitis. Nature Med. 2013;19(8):1005-13.
Blanchard C, Wang N, Stringer KF. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Investigation. 2006;116(2):536-47.
Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168(5):2464-9.
Allen-Brady K, Firszt R, Fang JC, Wong J, Smith KR, Peterson KA. Population-based familial aggregation of eosinophilic esophagitis suggests a genetic contribution. J Aller Clin Immunol. 2017;140(4):1138-43.
Alexander ES, Martin LJ, Collins MH. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Aller Clin Immunol. 2014;134(5):1084-92.
Blanchard C, Stucke EM, Burwinkel K. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033-41.
Rothenberg ME, Spergel JM, Sherrill JD. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nature Genetics. 2010;42(4):289-91.
Kottyan LC, Davis BP, Sherrill JD. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nature Genetics. 2014;46(8):895-900.
Sleiman P, Wang M-L, Cianferoni A. GWAS identifies four novel eosinophilic esophagitis loci. Nature Communications. 2014;5(1):1-5.
Spergel JM, Brown-Whitehorn TF, Beausoleil JL. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutrit. 2009;48(1):30-6.
Assa'ad AH, Putnam PE, Collins MH. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Aller Clin Immunol. 2007;119(3):731-8.
Iwanczak B, Janczyk W, Ryzko J. Eosinophilic esophagitis in children: frequency, clinical manifestations, endoscopic findings, and seasonal distribution. Adv Med Sci. 2011;56(2):151-7.
Moawad F, Veerappan G, Lake J. Correlation between eosinophilic oesophagitis and aeroallergens. Alimentar Pharmacol Therap. 2010;31(4):509-15.
Ram G, Lee J, Ott M. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Aller Asthma Immunol. 2015;115(3):224-8.
Cheung KM, Oliver MR, Cameron DJ, Catto-Smith AG, Chow CW. Esophageal eosinophilia in children with dysphagia. J Pediatr Gastroenterol Nutr. 2003;37(4):498-503.
Furuta GT. Clinicopathologic features of esophagitis in children. Gastrointestinal Endoscopy Clin N Am. 2001;11(4):683-715.
Langdon DE. "Congenital" esophageal stenosis, corrugated ringed esophagus, and eosinophilic esophagitis. Am J Gastroenterol. 2000;95(8):2123.
Gupta SK, Fitzgerald JF, Chong SK, Croffie JM, Collins MH. Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children? Gastrointestinal Endoscopy. 1997;45(6):485-9.
Teitelbaum JE, Fox VL, Twarog FJ. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122(5):1216-25.
Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Aller Clin Immunol. 2002;109(2):363-8.
Faubion Jr WA, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutrit. 1998;27(1):90-3.
Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26(4):380-5.
Garrett JK, Jameson SC, Thomson B. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Aller Clin Immunol. 2004;113(1):115-9.
Ortega HG, Liu MC, Pavord ID. Mepolizumab treatment in patients with severe eosinophilic asthma. N Eng J Med. 2014;371(13):1198-207.
Straumann A, Conus S, Grzonka P. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59(01):21-30.
Stein ML, Collins MH, Villanueva JM. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Aller Clin Immunol. 2006;118(6):1312-9.
Spergel JM, Rothenberg ME, Collins MH. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Aller Clin Immunol. 2012;129(2):456-63.
Assa'ad AH, Gupta SK, Collins MH. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593-604.
Rothenberg ME, Wen T, Greenberg A. Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;135(2):500-7.
Clayton F, Fang JC, Gleich GJ. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602-9.
Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointestinal Endoscopy. 2014;79(4):577-85.
Schoepfer AM, Safroneeva E, Bussmann Cl. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230-36.
Aceves S, Newbury R, Chen D. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65(1):109-16.
Muir AB, Merves J, Liacouras CA. Role of endoscopy in diagnosis and management of pediatric eosinophilic esophagitis. Gastrointestinal Endoscopy Clin. 2016;26(1):187-200.
Downloads
Published
How to Cite
Issue
Section
